 Co-Diagnostics Incs NASDAQ: CODX Q2 revenue increased 14 YY to 27.4 million, primarily due to Logix Smart COVID-19 Test sales, beating the consensus of 20.77 million. Gross profit increased 37.6 to 24.9 million, with margin expanding to 90.8 from 75.1 in Q2 FY20 due to reduced production costs and improved product mix compared to the prior-year period. 